1. Home
  2. BFH vs BLTE Comparison

BFH vs BLTE Comparison

Compare BFH & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bread Financial Holdings Inc.

BFH

Bread Financial Holdings Inc.

HOLD

Current Price

$69.12

Market Cap

3.5B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$166.39

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFH
BLTE
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.1B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BFH
BLTE
Price
$69.12
$166.39
Analyst Decision
Hold
Strong Buy
Analyst Count
17
8
Target Price
$68.53
$161.57
AVG Volume (30 Days)
924.3K
237.7K
Earning Date
01-29-2026
03-16-2026
Dividend Yield
1.32%
N/A
EPS Growth
55.00
N/A
EPS
9.68
N/A
Revenue
$2,509,000,000.00
N/A
Revenue This Year
$58.62
N/A
Revenue Next Year
$3.51
N/A
P/E Ratio
$7.17
N/A
Revenue Growth
1.70
N/A
52 Week Low
$38.21
$49.00
52 Week High
$82.03
$174.78

Technical Indicators

Market Signals
Indicator
BFH
BLTE
Relative Strength Index (RSI) 41.97 63.97
Support Level $68.07 $156.52
Resistance Level $70.80 $174.78
Average True Range (ATR) 2.26 8.80
MACD -0.72 0.13
Stochastic Oscillator 9.19 73.96

Price Performance

Historical Comparison
BFH
BLTE

About BFH Bread Financial Holdings Inc.

Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: